ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

Q: What does CUSIP 82835W108 represent in this 13F holders report?

CUSIP 82835W108 is the security identifier for SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in Q4 2023?

99 institutional investors reported SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share for Q4 2023. Use the holders table for investor-level position and value details.

CUSIP: 82835W108

Q4 2023 13F Holders as of 31 Dec 2023

Security type / class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 99,255,583
Total 13F shares: 65,423,068
Share change: -1,107,252
Total reported value: $358,517,051
Put/Call ratio: 32%
Reported price per share: $5.48
Number of holders: 99
Value change: -$2,784,476
Number of buys: 47
Number of sells: 43

Security key

82835W108

Report period

Q4 2023

Institutions

Top holders

SPRY full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2024 Previous quarter: Q3 2023 ARS Pharmaceuticals, Inc. SEC filings ARS Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 82835W108

Newer quarter: Q1 2024 Previous quarter: Q3 2023

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

DEERFIELD MANAGEMENT COMP...

13D/G signal

—

Evidence rows

Latest as of

30 Sep 2023

13F Lead comparable stake: 11% Showing 1-6 of 15 holder rows.

Rank 1 holder

DEERFIELD MANAGEMENT COMPANY, L.P.

13F

Ownership: 11%
Position: $41.87M

13F

Rank 2 holder

RA CAPITAL MANAGEMENT, L.P.

13F

Ownership: 9.5%
Position: $35.76M

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
DEERFIELD MANAGEMENT COMPANY, L.P.	13F Company 13F	11%	$41,874,564 11,077,927 shares	—	30 Sep 2023
RA CAPITAL MANAGEMENT, L.P.	13F Company 13F	9.5%	$35,757,583 9,459,678 shares	—	30 Sep 2023
ORBIMED ADVISORS LLC	13F Company 13F	9.3%	$34,930,553 9,240,887 shares	—	30 Sep 2023
Charles Schwab Trust Co	13F Company 13F	4.3%	$16,050,148 4,246,071 shares	—	30 Sep 2023
SR ONE CAPITAL MANAGEMENT, LP	13F Company 13F	4%	$15,168,773 4,012,903 shares	—	30 Sep 2023
FRANKLIN RESOURCES INC	13F Company 13F	3.9%	$14,622,964 3,868,509 shares	—	30 Sep 2023

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

65,423,068

Rows available

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

Q4 2023 holders

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 value	Q4 2023 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend